Todos Medical (Todos Medical) Growth Rank : 0 (As of May. 17, 2024)

View and export this data going back to 2017. Start your Free Trial

What is Todos Medical Growth Rank?

Todos Medical has the Growth Rank of 0.

GuruFocus Growth Rank measures the growth of a company in terms of its revenue and profitability. Historically, the companies with the highest growth ranks performed the best over the long term. It is calculated using the following criteria:

1. 5-year revenue growth rate, the higher, the better.
2. 3-year revenue growth rate, the higher, the better.
3. 5-year EBITDA growth rate, the higher, the better.
4. The predictability of 5-year revenue. The most consistent it is, the higher the rank.

GuruFocus found that the Growth Rank is the second of the two most-sensitive parameters among the five parameters checked. Please click GF Score to see more details on GF Score's 5 Key Aspects of Analysis.

Please note that we are using the five-year EBITDA growth rate as a parameter, so the company needs to have had positive growth over that time. The reason we use EBITDA instead of earnings per share is that with EBITDA, we can rank a lot more companies since a company may have positive EBITDA but negative EPS. Since we are looking at the growth here, EBITDA gives us a pretty clear picture about the growth in the company's business operations.

Todos Medical Growth Rank Related Terms

Thank you for viewing the detailed overview of Todos Medical's Growth Rank provided by GuruFocus.com. Please click on the following links to see related term pages.

Todos Medical (Todos Medical) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Todos Medical Ltd (OTCPK:TOMDF) » Definitions » Growth Rank

Comparable Companies

Traded in Other Exchanges

N/A

Address

121 Derech Menachem Begin, 30th Floor, Tel Aviv, ISR, 6701203

Website

https://www.todosmedical.com

Todos Medical Ltd is an in vitro diagnostics company. Its operating segments are Breast Cancer Test, Alzheimer's, and COVID-19 testing. The company generates all of its revenue from the United States.

Executives

Gerald Commissiong	director, officer: CEO and Director	675 ALMANOR AVENUE, SUNNYVALE CA 94085
Strategic Investment Holdings, Llc	10 percent owner	875 CARRETERA 693, SUITE 201, DORADO PR 00646